TY - JOUR
T1 - A novel homozygous deletion in EXPH5 causes a skin fragility phenotype
AU - Malchin, N.
AU - Sarig, O.
AU - Grafi-Cohen, M.
AU - Geller, S.
AU - Goldberg, I.
AU - Shani, A.
AU - Gat, A.
AU - Sprecher, E.
AU - Mashiah, J.
N1 - Publisher Copyright:
© 2016 British Association of Dermatologists
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Epidermolysis bullosa simplex (EBS) is the most common form of EB. Eight different genes have been implicated in the pathogenesis of different types of EBS, but a substantial portion of the cases cannot be attributed to mutations in known genes. Recently, recessive mutations in the gene EXPH5 (encoding exophilin-5, also known as Slac2-b) were identified in patients affected with a mild form of EBS. We used immunohistochemistry, Sanger sequencing and PCR–restriction fragment length polymorphism analysis to identify the cause of mild congenital skin fragility in a 3-year-old girl. No mutations were detected in KRT5 or KRT14, but we identified a novel homozygous deletion in EXPH5, which was found to cosegregate with the disease phenotype in the family. Our results further expand the spectrum of mutations in EXPH5. Appraisal of the present case against previously reported patients indicate that EXPH5 mutations result in a distinctive skin fragility phenotype, with minimal blistering compared with other forms of basal EBS.
AB - Epidermolysis bullosa simplex (EBS) is the most common form of EB. Eight different genes have been implicated in the pathogenesis of different types of EBS, but a substantial portion of the cases cannot be attributed to mutations in known genes. Recently, recessive mutations in the gene EXPH5 (encoding exophilin-5, also known as Slac2-b) were identified in patients affected with a mild form of EBS. We used immunohistochemistry, Sanger sequencing and PCR–restriction fragment length polymorphism analysis to identify the cause of mild congenital skin fragility in a 3-year-old girl. No mutations were detected in KRT5 or KRT14, but we identified a novel homozygous deletion in EXPH5, which was found to cosegregate with the disease phenotype in the family. Our results further expand the spectrum of mutations in EXPH5. Appraisal of the present case against previously reported patients indicate that EXPH5 mutations result in a distinctive skin fragility phenotype, with minimal blistering compared with other forms of basal EBS.
UR - http://www.scopus.com/inward/record.url?scp=84991059298&partnerID=8YFLogxK
U2 - 10.1111/ced.12908
DO - 10.1111/ced.12908
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27730671
AN - SCOPUS:84991059298
VL - 41
SP - 915
EP - 918
JO - Clinical and Experimental Dermatology
JF - Clinical and Experimental Dermatology
SN - 0307-6938
IS - 8
ER -